Moore Daniel Jeffrey
Known title: DirectorCIK: 0001400857
Associated companies
Transaction History
| LIVN | ▲ Buy | Option Exercise | 56,623 | $3.2M | 6/3/2024 | View on chart |
| LIVN | ▼ Sell | Open Market | 54,578 | $3.3M | 6/3/2024 | View on chart |
| LIVN | ▼ Sell | Open Market | 2,045 | $125K | 6/3/2024 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 2,082 | $0 | 6/15/2023 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 444 | $21K | 6/15/2023 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 80 | $5K | 6/15/2022 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 1,346 | $0 | 6/15/2022 | View on chart |
| LIVN | ▼ Sell | Open Market | 1,000 | $83K | 4/1/2022 | View on chart |
| LIVN | ▼ Sell | Open Market | 1,000 | $80K | 3/2/2022 | View on chart |
| LIVN | ▼ Sell | Open Market | 1,000 | $80K | 2/25/2022 | View on chart |
| LIVN | ▼ Sell | Open Market | 1,000 | $86K | 1/3/2022 | View on chart |
| LIVN | ▼ Sell | Open Market | 1,000 | $82K | 12/1/2021 | View on chart |
| LIVN | ▼ Sell | Open Market | 1,000 | $85K | 11/3/2021 | View on chart |
| LIVN | ▼ Sell | Open Market | 1,000 | $80K | 10/1/2021 | View on chart |
| LIVN | ▼ Sell | Open Market | 1,000 | $82K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
LivaNova Shares Rise on Barclays Overweight Rating
Barclays has begun coverage of LivaNova, giving it an overweight rating and a $105 price target. The stock is currently trading near the upper end of its 52‑week range and has been on a 60% three‑year run, which some analysts see as undervalued. Technical indicators show an RSI of 45 and a support level at $78.13, with a support reject signal that may signal a short‑term consolidation.
LivaNova Shares Rise on Barclays Overweight Rating. Barclays has begun coverage of LivaNova, giving it an overweight rating and a $105 price target. The stock is currently trading near the upper end of its 52‑week range and has been on a 60% three‑year run, which some analysts see as undervalued. Technical indicators show an RSI of 45 and a support level at $78.13, with a support reject signal that may signal a short‑term consolidation.